申请人:Imperial Chemical Industries PLC
公开号:US05189033A1
公开(公告)日:1993-02-23
The invention relates to tricyclic heterocycles, or pharmaceutically-acceptable salts thereof, which possess anti-hyperalgesic properties. The invention also relates to processes for the manufacture of said tricyclic heterocycles; and to novel pharmaceutical compositions containing them. The invention provides a tricyclic heterocycle of the formula I ##STR1## wherein X is oxy, thio, sulphinyl, sulphonyl, amino, (1-4C)alkylamino or methylene; Y is carbonyl or methylene; each R.sup.1 includes hydrogen and halogeno; each of m and n is 1 or 2; each of A.sup.1 and A.sup.2 is a direct link, alkylene, alkenylene or alkynylene; Ar is phenylene which may optionally bear one or two substituents; and G is carboxy, 1H-tetrazol-5-yl or a group of the formula: --CONH--SO.sub.2 R.sup.2 wherein R.sup.2 is (1-4C)alkyl, benzyl or phenyl; or a pharmaceutically-acceptable salt thereof.
该发明涉及三环杂环化合物或其药用盐,具有抗高反感性特性。该发明还涉及制备所述三环杂环化合物的方法;以及含有它们的新型药物组合物。该发明提供了具有以下结构的三环杂环化合物:其中X为氧、硫、亚砜基、磺酰基、氨基、(1-4C)烷基氨基或亚甲基;Y为羰基或亚甲基;每个R.sup.1包括氢和卤素;m和n中的每一个为1或2;每个A.sup.1和A.sup.2为直链、烷基、烯基或炔基;Ar为苯基,可以选择性地带有一个或两个取代基;G为羧基、1H-四唑-5-基或具有以下结构的基团:--CONH--SO.sub.2 R.sup.2,其中R.sup.2为(1-4C)烷基、苄基或苯基;或其药用盐。